Sequoia Sciences
Sequoia Sciences Sequoia Sciences
High-throughput Natural Products Chemistry

About Us Science & Technologies Research & Development Publications Contact

Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers. Our development programs consist of small molecules targeting bacterial infections and cancers, and also vaccines for the treatment and prevention of recurrent urinary tract infections. Sequoia is engaged in research and development programs and collaborations with laboratories, universities, clinical research sites, and private businesses. Our goal is to improve the quality of life for those individuals significantly affected by recurrent and chronic bacterial infections and cancers.


Recent Publications | See All

February 2014: Starks, C.M.; Williams, R.B.; Norman, V.L.; Rice, S.M.; O'Neil-Johnson, M.A.; Lawrence, J.A.; Eldridge, G.R. "Antibacterial Chromene and Chromane Stilbenoids from Hymenocardia acida." Phytochemistry, 2014, 98,216-222

August 2013: Williams, Russell; Norman, Vanessa; Goering, Matt; O'Neil-Johnson, Mark; Eldridge, Gary; Starks, Courtney "Acetylated Dammarane-type Bisdesmosides from Combretum inflatum." Journal of Natural Products, 2013, 76, 1592-1597

June 2012: Starks, C.M.; Williams, R.B.; Norman, V.L.; Lawrence, J.A.; O'Neil-Johnson, M.A.; Eldridge, G.R. "Phenylpropanoids from Phragmipedium calurum and their Antiproliferative Activity." Phytochemistry, 2012, 82, 172-175

June 2012: Williams, R.B.; Martin, S.M.; Hu, J.F.; Norman, V.L.; Goering, M.G.; Loss, S.; O'Neil-Johnson, M.A.; Eldridge, G.R.; Starks, C.M. "Cytotoxic and Antibacterial Beilschmiedic Acids from a Gabonese Species of Beilschmiedia." Journal of Natural Products, 2012, 75, 1319-1325